(2) Where a drug is not manufactured by the person whose name appears on the label, the name and location address of the manufacturer shall be indicated by a phrase that reveals the connection with the person e.g. “Manufactured by……….for…………..”., ‘Manufactured for…………by……………..”, or any other wording that expresses the facts. 6. Display of proper name, brand name etc. (1) The packaging components of a drug shall bear the name, active ingredients, strength and dosage form of the drug. (2) The outer and inner labels of a drug shall show the generic name and strength thereof. (3) Where a drug is branded, the generic and brand names shall be reflected on the outer and inner labels. (4) The name shall prominently appear on the principal display panel of the package to aid accurate identification. (5) Where a drug contains a single active ingredient, the common or generic name shall appear in conjunction and in close proximity to the brand name (if any) of the drug. (6) Where a drug contains more than one active ingredient, all the common names shall appear on the principal display panel of the drug. However, if the drug is packaged in a container too small to bear this information, it may appear elsewhere on the label. (7) The location address of the manufacturer of a drug shall be complete on the outer label, unless the immediate container of the drug contains 5 ml (or equivalents) or less of the drug product, in which case the address need not be shown on the inner label. 7. Declaration of net content of drug (1) The outer label of a drug shall indicate :- 8. (a) the net content of the drug in the container in terms of unit weight, measure or number ; and (b) for sterile drugs, a quantitative list of preservatives present therein shall be indicated where applicable by their generic or common names. Trade mark (a) where a drug product have a trade mark displayed on the label, the trade mark shall not give a wrong impression of the nature, quality or substance of the drug product; (b) where the trademark registration is in conflict with any regulations or requirements of the Agency, the latter shall supercede. 2